---
title: TwinF interface inhibitor FP802 prevents retinal ganglion cell loss in a mouse
  model of amyotrophic lateral sclerosis
date: '2024-09-12'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39267142/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240913201225&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Motor neuron loss is well recognized in amyotrophic lateral sclerosis
  (ALS), but research on retinal ganglion cells (RGCs) is limited. Ocular symptoms
  are generally not considered classic ALS symptoms, although RGCs and spinal motor
  neurons share certain cell pathologies, including hallmark signs of glutamate neurotoxicity,
  which may be triggered by activation of extrasynaptic NMDA receptors (NMDARs). To
  explore potential novel strategies to prevent ALS-associated death of RGCs, we ...
disable_comments: true
---
Motor neuron loss is well recognized in amyotrophic lateral sclerosis (ALS), but research on retinal ganglion cells (RGCs) is limited. Ocular symptoms are generally not considered classic ALS symptoms, although RGCs and spinal motor neurons share certain cell pathologies, including hallmark signs of glutamate neurotoxicity, which may be triggered by activation of extrasynaptic NMDA receptors (NMDARs). To explore potential novel strategies to prevent ALS-associated death of RGCs, we ...